Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide
Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
Authors: Paola Papaldo, Massimo Lopez, Enrico Cortesi, Eugenio Cammilluzzi, Mauro Antimi, Edmondo Terzoli, Giuseppe Lepidini, Patrizia Vici, Carlo Barone, Gianluigi Ferretti, Serena Di Cosimo, Cecilia Nisticò, Paolo Carlini, Francesca Conti, Luigi Di Lauro, Claudio Botti, Carlo Vitucci, Alessandra Fabi, Diana Giannarelli, Paolo Marolla
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2139754445
